모노필라멘트 합성 흡수성 봉합사 시장 : 세계 예측(2026-2032년)

The Monofilament Synthetic Absorbable Sutures Market is projected to grow by USD 1,044.76 million at a CAGR of 8.04% by 2032.

Monofilament synthetic absorbable sutures are sterile, single-strand wound-closure materials designed to approximate tissue while gradually losing tensile strength through hydrolytic absorption. Their use is concentrated in procedures where smooth passage, reduced tissue drag, and elimination of later suture removal are clinically valuable. Product selection depends on tissue type, healing time, handling characteristics, knot security, diameter, coating, and applicable regulatory requirements.

Transformative Shifts in Absorbable Suture Practice

Clinical practice is shifting toward materials that combine predictable absorption with reliable handling and lower procedural burden. Hospitals and surgical centers are placing greater emphasis on infection-control protocols, traceability, ergonomic packaging, and consistent needle-suture performance. Minimally invasive procedures, ambulatory surgery, and enhanced recovery pathways also favor sutures that can be delivered efficiently through small access points and remain appropriate for planned postoperative healing.

Artificial Intelligence's Cumulative Impact on Suture Demand

Artificial intelligence is influencing this field indirectly through surgical planning, image-supported tissue assessment, operating-room workflow optimization, and quality monitoring. Decision-support tools may help clinicians standardize closure approaches by linking procedure characteristics with tissue condition and healing considerations, while computer vision can support documentation and detection of postoperative complications. Manufacturers and providers can also use AI for demand planning, lot traceability, adverse-event surveillance, and process optimization, but clinical validation, cybersecurity, explainability, and human oversight remain essential.

Regional Insights Across Six Healthcare Landscapes

North America emphasizes regulatory compliance, hospital value analysis, ambulatory surgery, and evidence-based procurement. Europe places strong weight on device safety, environmental considerations, harmonized quality systems, and outcomes-focused purchasing. Asia-Pacific combines advanced surgical centers with rapidly expanding access and substantial variation in reimbursement and infrastructure. Latin America is shaped by public-private healthcare differences, import dependence in some markets, and demand for dependable products with practical procurement support. The Middle East is investing in specialized surgical capacity and centralized healthcare systems, while Africa presents a diverse landscape in which affordability, supply continuity, workforce training, and access to sterile products are critical priorities.

Group-Level Priorities Across Major Economic and Security Blocs

ASEAN markets require adaptable distribution, localized training, and solutions suited to varied hospital capabilities. BRICS members show diverse regulatory, manufacturing, reimbursement, and public-procurement conditions, making country-specific execution important. The European Union prioritizes common safety and quality expectations alongside sustainability and cross-border compliance. G7 healthcare systems generally demand strong clinical documentation, supply assurance, and integration with sophisticated procurement processes. GCC countries emphasize high-quality imported and locally supported medical technologies within centralized or strategically coordinated healthcare systems. NATO members span different regulatory environments, but many share priorities around resilient medical supply chains, emergency preparedness, and dependable access to essential surgical products.

Country-Level Considerations for Market Engagement

Australia favors evidence-led hospital procurement and strong regulatory governance. Brazil combines a large and varied healthcare system with complex public purchasing and domestic-production considerations. Canada emphasizes safety, institutional evaluation, and access across geographically dispersed care settings. China is advancing domestic medical-device capability while maintaining demanding registration and procurement requirements. France, Germany, Italy, and Spain operate within European regulatory expectations but differ in hospital purchasing structures, reimbursement practices, and adoption pathways. India combines high procedure volume and expanding care access with pronounced variation in facility resources and price sensitivity. Japan values product reliability, precise handling, and rigorous approval processes. Mexico presents opportunities linked to surgical access and private healthcare while requiring attention to procurement and distribution complexity. Russia's operating environment is influenced by domestic supply priorities, regulatory conditions, and logistical constraints. South Korea combines advanced hospitals with technology-oriented procurement. The United Kingdom emphasizes clinical governance, centralized purchasing influences, and value-based evaluation. The United States places strong emphasis on regulatory compliance, hospital contracting, ambulatory surgery, and documented clinical performance.

Actionable Recommendations for Industry Leaders

Leaders should segment portfolios by tissue application, absorption profile, needle configuration, and care setting rather than relying on a single universal proposition. Strengthen clinical evidence, handling demonstrations, and educational support for surgeons and operating-room staff. Build resilient, multi-source supply chains with robust lot traceability and contingency inventory for essential sizes. Align regulatory, reimbursement, and procurement strategies with local requirements, especially where public tenders or centralized purchasing dominate. Use digital tools and carefully governed AI for demand planning, complaint surveillance, and workflow support, while protecting patient data and preserving clinician accountability. Sustainability initiatives should focus on packaging reduction, efficient logistics, and measurable lifecycle improvements without compromising sterility or product performance.

Research Methodology for the Executive Summary

This executive summary is based on the supplied market definition and a structured qualitative assessment of the product category, clinical-use context, regulatory considerations, technology trends, healthcare-system characteristics, and the required regional, group, and country lenses. Insights are framed without market estimates, forecasts, market shares, or company-specific references. Interpretation should be supplemented with current regulatory filings, peer-reviewed clinical evidence, procurement documents, adverse-event databases, and interviews with qualified healthcare professionals before use in investment, product, or commercialization decisions.

Conclusion: Competing Through Reliability and Clinical Fit

Monofilament synthetic absorbable sutures occupy an important role in modern wound closure because they can provide smooth handling, predictable absorption, and reduced need for follow-up removal. Success increasingly depends on more than material selection: manufacturers and healthcare providers must demonstrate clinical suitability, maintain dependable sterile supply, meet evolving regulatory expectations, and support efficient surgical workflows. Organizations that pair evidence-based product design with regional execution, responsible digital adoption, and strong quality systems will be best positioned to serve varied healthcare environments.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Monofilament Synthetic Absorbable Sutures Market, by Product Type

• 7.1. Introduction
• 7.2. Polydioxanone
• 7.3. Polyglecaprone
• 7.4. Polytrimethylene Carbonate

8. Monofilament Synthetic Absorbable Sutures Market, by Application

• 8.1. Introduction
• 8.2. Cardiovascular Surgery
• 8.3. General Surgery
• 8.4. Gynecological Surgery
• 8.5. Ophthalmic Surgery
• 8.6. Orthopedic Surgery
• 8.7. Plastic Surgery
• 8.8. Urological Surgery

9. Monofilament Synthetic Absorbable Sutures Market, by End User

• 9.1. Introduction
• 9.2. Ambulatory Surgical Centers
• 9.3. Hospitals
• 9.4. Specialty Clinics

10. Monofilament Synthetic Absorbable Sutures Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Direct Sales
• 10.3. Distributors
• 10.4. E-Commerce

11. Monofilament Synthetic Absorbable Sutures Market, by Region

• 11.1. Introduction
• 11.2. Asia-Pacific
• 11.3. North America
• 11.4. Latin America
• 11.5. Europe
• 11.6. Middle East
• 11.7. Africa

12. Monofilament Synthetic Absorbable Sutures Market, by Group

• 12.1. Introduction
• 12.2. ASEAN
• 12.3. GCC
• 12.4. European Union
• 12.5. BRICS
• 12.6. G7
• 12.7. NATO

13. Monofilament Synthetic Absorbable Sutures Market, by Country

• 13.1. Introduction
• 13.2. United States
• 13.3. Canada
• 13.4. Mexico
• 13.5. Brazil
• 13.6. United Kingdom
• 13.7. Germany
• 13.8. France
• 13.9. Russia
• 13.10. Italy
• 13.11. Spain
• 13.12. China
• 13.13. India
• 13.14. Japan
• 13.15. Australia
• 13.16. South Korea

14. Competitive Landscape

• 14.1. Market Share Analysis, 2025
• 14.2. Market Concentration Analysis, 2025
  • 14.2.1. Concentration Ratio (CR)
  • 14.2.2. Herfindahl Hirschman Index (HHI)
• 14.3. Recent Developments & Impact Analysis, 2025
• 14.4. Product Portfolio Analysis, 2025
• 14.5. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. Aspen Surgical Products Inc
• 15.2. B. Braun Melsungen AG
• 15.3. DemeTECH Corporation
• 15.4. Dolphin Sutures
• 15.5. Ethicon Inc
• 15.6. Genesis Medtech
• 15.7. Healthium Medtech Limited
• 15.8. Lohmann & Rauscher GmbH & Co KG
• 15.9. Lotus Surgicals Pvt Ltd
• 15.10. Medico
• 15.11. Medtronic plc
• 15.12. Orion Sutures India Pvt Ltd
• 15.13. Resorba Medical GmbH
• 15.14. Samyang Biopharm Co Ltd
• 15.15. Smith & Nephew plc
• 15.16. Suture Planet
• 15.17. Sutures India Pvt Ltd
• 15.18. Teleflex Incorporated
• 15.19. Unisur Lifecare

16. Key Experts